Issue 5/2016

Multiple myeloma, immunotherapy and minimal residual disease (651 — 658)

J. KUSENDA, A. KOVARIKOVA

DOI: 10.4149/neo_2016_501

Incidence of preleukemic fusion genes in healthy subjects (659 — 672)

P. KOSIK, M. SKORVAGA, I. BELYAEV

DOI: 10.4149/neo_2016_502

MiR-129-5p is down-regulated and involved in migration and invasion of gastric cancer cells by targeting interleukin-8 (673 — 680)

Z. JIANG, H. WANG, Y. LI, Z. HOU, N. MA, W. CHEN, Z. ZONG, S. CHEN

DOI: 10.4149/neo_2016_503

Frameshift mutations of OGDH, PPAT and PCCA genes in gastric and colorectal cancers (681 — 686)

Y. S. JO, H. R. OH, M. S. KIM, N. J. YOO, S. H. LEE

DOI: 10.4149/neo_2016_504

Activation of the ER stress and calcium signaling in angiomyolipoma (687 — 695)

B. NOVOTNA, M. TAKACOVA, S. HUDECOVA, L. LENCESOVA, J. BREZA JR., A. MISAK, L. CSADEROVA, S. PASTOREKOVA, O. KRIZANOVA, J. BREZA

DOI: 10.4149/neo_2016_505

MicroRNA-433 inhibits migration and invasion of ovarian cancer cells via targeting Notch1 (696 — 704)

T. LIANG, Q. GUO, L. LI, Y. CHENG, C. REN, G. ZHANG

DOI: 10.4149/neo_2016_506

B-cell translocation gene 3 overexpression inhibits proliferation and invasion of colorectal cancer SW480 cells via Wnt/β-catenin signaling pathway (705 — 716)

D. MAO, L. QIAO, H. LU, Y. FENG

DOI: 10.4149/neo_2016_507

MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R (717 — 725)

X. WANG, H. LI, L. CUI, J. FENG, Q. FAN

DOI: 10.4149/neo_2016_508

Noscapine inhibits human hepatocellular carcinoma growth through inducing apoptosis in vitro and in vivo (726 — 733)

G. XU, Z. NIU, J. DONG, Y. ZHAO, Y. ZHANG, X. LI

DOI: 10.4149/neo_2016_509

Notch1 is associated with the multidrug resistance of hypoxic osteosarcoma by regulating MRP1 gene expression (734 — 742)

C. LI, D. GUO, B. TANG, Y. ZHANG, K. ZHANG, L. NIE

DOI: 10.4149/neo_2016_510

The quality of life following allogeneic hematopoietic stem cell transplantation – a multicenter retrospective study (743 — 751)

V. VALKOVA, J. JIRCIKOVA, M. TRNKOVA, K. STEINEROVA, P. KESLOVA, M. LANSKA, Z. KORISTEK, L. RAIDA, M. KREJCI, K. KRUNTORADOVA, T. DOLEZAL, K. BENESOVA, P. CETKOVSKY, M. TRNENY

DOI: 10.4149/neo_2016_511

The role of CRP, PCT, IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haemato-oncological patients (752 — 760)

M. PLESKO, J. SUVADA, M. MAKOHUSOVA, I. WACZULIKOVA, D. BEHULOVA, A. VASILENKOVA, M. VARGOVA, A. STECOVA, E. KAISEROVA, A. KOLENOVA

DOI: 10.4149/neo_2016_512

Retrospective analysis of efficacy of trastuzumab in adjuvant treatment of HER 2 positive early breast cancer – single institution experience (761 — 767)

M. BAN, J. VICULIN, S. TOMIC, V. CAPKUN, A. STRIKIC, B. PETRIC MISE, I. UTROBICIC, E. VRDOLJAK

DOI: 10.4149/neo_2016_513

Immune checkpoints in aggressive breast cancer subtypes (768 — 773)

I. ZAWLIK, N. GABLO, B. SZYMANSKA, Z. PAWLOWSKA, C. CHUDOBINSKI, J. CHALUBINSKA-FENDLER, Z. MORAWIEC, H. ZIELINSKA-BLIZNIEWSKA, A. MORAWIEC-SZTANDERA, A. KOLACINSKA

DOI: 10.4149/neo_2016_514

Single-agent cytarabine is insufficient for the treatment of human mantle cell lymphoma in mouse xenograft model (774 — 778)

M. KLANOVA, T. SOUKUP, J. MOLINSKY, L. LATECKOVA, P. VOCKOVA, M. ALAM, J. ZIVNY, M. TRNENY, P. KLENER

DOI: 10.4149/neo_2016_515

Detection of oncogenic mutations in cervical carcinoma using method High Resolution Melting (HRM) (779 — 788)

M. WAYHELOVA, A. MIKULASOVA, J. SMETANA, V. VALLOVA, D. BLAZKOVA, H. FILKOVA, L. MOUKOVA, P. KUGLIK

DOI: 10.4149/neo_2016_516

Regulatory T cells are an important prognostic factor in breast cancer: a systematic review and meta-analysis (789 — 798)

Y. WANG, J. SUN, R. ZHENG, Q. SHAO, W. GAO, B. SONG, X. CHEN, X. QU

DOI: 10.4149/neo_2016_517

MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection (799 — 808)

S. POSPISILOVA, E. PAZOURKOVA, A. HORINEK, A. BRISUDA, I. SVOBODOVA, V. SOUKUP, J. HRBACEK, O. CAPOUN, T. HANUS, J. MARES, M. KORABECNA, M. BABJUK

DOI: 10.4149/neo_2016_518

Clinical value of high expression level of CD71 in acute myeloid leukemia (809 — 815)

B. WU, N. SHI, L. SUN, L. LIU

DOI: 10.4149/neo_2016_519

The impact of p16 and HER2 expression on survival in patients with ovarian carcinoma (816 — 821)

F. H. SHANDIZ, S. KADKHODAYAN, K. GHAFFARZADEGAN, H. ESMAEILY, S. TORABI, S. A. KHALES

DOI: 10.4149/neo_2016_520